Role of the circular RNAs/microRNA/messenger RNA axis in renal cell carcinoma: From gene regulation to metabolism and immunity

IF 4.6 2区综合性期刊 Q1 MULTIDISCIPLINARY SCIENCES

iScience Pub Date : 2025-03-11 DOI:10.1016/j.isci.2025.112183

Zhe Xu , Yurong Dong , Kun Cui , Bin Hu , Ying Lu , Xiangjie Liu , Asif Shahzad , Jinshan Zhang , Qiuxin Duan , Ziyuan Bai , Dongmei Peng , Jiaojiao Xia , Wenjing Liu , Zhuoran Teng , Zhe Yang , Qiao Zhang

{"title":"Role of the circular RNAs/microRNA/messenger RNA axis in renal cell carcinoma: From gene regulation to metabolism and immunity","authors":"Zhe Xu , Yurong Dong , Kun Cui , Bin Hu , Ying Lu , Xiangjie Liu , Asif Shahzad , Jinshan Zhang , Qiuxin Duan , Ziyuan Bai , Dongmei Peng , Jiaojiao Xia , Wenjing Liu , Zhuoran Teng , Zhe Yang , Qiao Zhang","doi":"10.1016/j.isci.2025.112183","DOIUrl":null,"url":null,"abstract":"<div><div>Renal cell carcinoma (RCC), particularly clear cell RCC (ccRCC), has seen rising incidence and mortality rates. Early detection remains difficult due to nonspecific symptoms, often leading to diagnoses at advanced stages and unfavorable prognoses. Current treatments, including surgery, targeted therapies, and immunotherapies, face limitations such as adverse reactions, drug resistance, and immune evasion. This review discusses the role of circular RNAs (circRNAs) and their involvement in the circRNA/miRNA/mRNA axis during RCC progression. As competitive endogenous RNAs (ceRNAs), circRNAs regulate gene expression and cellular processes, including proliferation, metastasis, apoptosis, and drug resistance. Furthermore, we explore the impact of circRNAs on tumor metabolic reprogramming and their influence on the immune microenvironment. We also summarize the clinical prospects, challenges, and future directions in this field. A comprehensive understanding of these complex interactions may provide new insights into the diagnosis and treatment of RCC, ultimately overcoming existing challenges and improving patient outcomes.</div></div>","PeriodicalId":342,"journal":{"name":"iScience","volume":"28 4","pages":"Article 112183"},"PeriodicalIF":4.6000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"iScience","FirstCategoryId":"103","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589004225004444","RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}

引用次数: 0

Abstract

Renal cell carcinoma (RCC), particularly clear cell RCC (ccRCC), has seen rising incidence and mortality rates. Early detection remains difficult due to nonspecific symptoms, often leading to diagnoses at advanced stages and unfavorable prognoses. Current treatments, including surgery, targeted therapies, and immunotherapies, face limitations such as adverse reactions, drug resistance, and immune evasion. This review discusses the role of circular RNAs (circRNAs) and their involvement in the circRNA/miRNA/mRNA axis during RCC progression. As competitive endogenous RNAs (ceRNAs), circRNAs regulate gene expression and cellular processes, including proliferation, metastasis, apoptosis, and drug resistance. Furthermore, we explore the impact of circRNAs on tumor metabolic reprogramming and their influence on the immune microenvironment. We also summarize the clinical prospects, challenges, and future directions in this field. A comprehensive understanding of these complex interactions may provide new insights into the diagnosis and treatment of RCC, ultimately overcoming existing challenges and improving patient outcomes.

Abstract Image

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

iScience Multidisciplinary-Multidisciplinary

CiteScore

7.20

自引率

1.70%

发文量

1972

审稿时长

6 weeks

期刊介绍： Science has many big remaining questions. To address them, we will need to work collaboratively and across disciplines. The goal of iScience is to help fuel that type of interdisciplinary thinking. iScience is a new open-access journal from Cell Press that provides a platform for original research in the life, physical, and earth sciences. The primary criterion for publication in iScience is a significant contribution to a relevant field combined with robust results and underlying methodology. The advances appearing in iScience include both fundamental and applied investigations across this interdisciplinary range of topic areas. To support transparency in scientific investigation, we are happy to consider replication studies and papers that describe negative results. We know you want your work to be published quickly and to be widely visible within your community and beyond. With the strong international reputation of Cell Press behind it, publication in iScience will help your work garner the attention and recognition it merits. Like all Cell Press journals, iScience prioritizes rapid publication. Our editorial team pays special attention to high-quality author service and to efficient, clear-cut decisions based on the information available within the manuscript. iScience taps into the expertise across Cell Press journals and selected partners to inform our editorial decisions and help publish your science in a timely and seamless way.